Image Source: Zacks Investment Research Sanofi announced its intention to separate its CHC unit last year through the ...

Sanofi and CD&R are joining forces to fuel Opella’s ambitions as a French-headquartered, global consumer healthcare champion. Sanofi and CD&R have entered exclusive negotiations for the ...

Sanofi (SNY) has released an update. Sanofi reported a robust 15.7% growth in sales for Q3 2024, driven by strong performances in its vaccine and pharmaceutical segments, notably with Dupixent ...

Sanofi on Friday said it’s in talks with the private equity firm CD&R to sell just over half of its consumer healthcare business, in a deal that could yield billions of dollars for the French ...

Despite the commitments it faces in France, CD&R has been drawn to the Sanofi consumer health-care business due to the stable, cash-generative nature of the industry. The firm, which has expertise ...

Sanofi (NASDAQ:SNY) shares gained on Friday after the French pharma giant exceeded analysts' estimates with its Q3 thanks mainly to earlier-than-anticipated vaccine sales and a 22% YoY rise in ...

PARIS, Oct 21 (Reuters) - French drugmaker Sanofi (SASY.PA), opens new tab said on Monday it had entered exclusive talks to sell a 50% controlling stake in its consumer health business Opella to U ...

Sanofi (SNY) has released an update. Sanofi’s Dupixent has received EU approval as the first treatment for children aged one to 11 with ...

Sanofi SAN-0.92%decrease; red down pointing triangle is in discussions with the French government to address concerns officials raised about a potential sale of a controlling stake in the company ...

How Sanofi Was Caught in The Middle of a €16 Billion Public Brawl Aaron Kirchfeld, Pamela Barbaglia, Dinesh Nair, Ania Nussbaum and Swetha Gopinath Thu, Oct 24, 2024, 7:59 AM 12 min read ...

Despite the commitments it faces in France, CD&R has been drawn to the Sanofi consumer health-care business due to the stable, cash-generative nature of the industry. The firm, which has expertise in ...